title: EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression.
abstract: The role of EGCG, a major green tea catechin in breast cancer therapy is poorly understood. The present study tests the hypothesis that EGCG can inhibit the activation of HIF-1α and NFκB, and VEGF expression, thereby suppressing tumor angiogenesis and breast cancer progression. Sixteen eight-wk-old female mice (C57BL/6 J) were inoculated with 10^6 E0771 (mouse breast cancer) cells in the left fourth mammary gland fat pad. Eight mice received EGCG at 50-100 mg/kg/d in drinking water for 4 weeks. 8 control mice received drinking water only. Tumor size was monitored using dial calipers. At the end of the experiment, blood samples, tumors, heart and limb muscles were collected for measuring VEGF expression using ELISA and capillary density (CD) using CD31 immunohistochemistry. EGCG treatment significantly reduced tumor weight over the control (0.37 ± 0.15 vs. 1.16 ± 0.30 g; P < 0.01), tumor CD (109 ± 20 vs. 156 ± 12 capillary #/mm^2; P < 0.01), tumor VEGF expression (45.72 ± 1.4 vs. 59.03 ± 3.8 pg/mg; P < 0.01), respectively. But, it has no effects on the body weight, heart weight, angiogenesis and VEGF expression in the heart and skeletal muscle of mice. EGCG at 50 μg/ml significantly inhibited the activation of HIF-1α and NFκB as well as VEGF expression in cultured E0771 cells, compared to the control, respectively. These findings support the hypothesis that EGCG, a major green tea catechin, directly targets both tumor cells and tumor vasculature, thereby inhibiting tumor growth, proliferation, migration, and angiogenesis of breast cancer, which is mediated by the inhibition of HIF-1α and NFκB activation as well as VEGF expression.
authors: Cancer Institute, University of Mississippi Medical Center, Jackson, Mississippi 39216, USA. jgu@umc.edu.
authors: Jian-Wei
authors: JW
authors: Gu
authors: Kristina L
authors: KL
authors: Makey
authors: Kevan B
authors: KB
authors: Tucker
authors: Edmund
authors: E
authors: Chinchar
authors: Xiaowen
authors: X
authors: Mao
authors: Ivy
authors: I
authors: Pei
authors: Emily Y
authors: EY
authors: Thomas
authors: Lucio
authors: L
authors: Miele
references: Prostate. 2004 Apr 1;59(1):33-42
references: 14991864
references: Int J Cancer. 2005 Sep 20;116(5):734-9
references: 15849727
references: J Cell Biochem. 1999 Oct 1;75(1):1-12
references: 10462699
references: Cancer Res. 2006 Mar 1;66(5):2500-5
references: 16510563
references: Biochem Pharmacol. 2011 Dec 15;82(12):1807-21
references: 21827739
references: Microcirculation. 2004 Dec;11(8):689-97
references: 15726836
references: Am J Physiol Regul Integr Comp Physiol. 2009 Jul;297(1):R142-8
references: 19420288
references: Nat Med. 2003 Jun;9(6):669-76
references: 12778165
references: FEBS Lett. 1995 Jan 16;358(1):1-3
references: 7821417
references: J Clin Oncol. 1994 Mar;12(3):441-3
references: 7509850
references: Integr Cancer Ther. 2002 Sep;1(3):287-93; discussion 293
references: 14667286
references: Breast Cancer Res. 2012 Jun 19;14(3):209
references: 22713170
references: J Clin Oncol. 2011 Feb 20;29(6):632-8
references: 21205755
references: Am Heart J. 2004 Mar;147(3):401-11
references: 14999187
references: Biochem Biophys Res Commun. 2007 Mar 23;354(4):852-7
references: 17266926
references: Cancer Res. 2006 Jan 15;66(2):1234-40
references: 16424063
references: Cancer Res. 1993 Feb 1;53(3):587-91
references: 8425192
references: Clin Exp Metastasis. 1995 Jan;13(1):16-22
references: 7820952
references: Cancer Res. 2001 Jul 15;61(14):5407-14
references: 11454684
references: J Int Med Res. 2003 Mar-Apr;31(2):88-101
references: 12760312
references: Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10350-5
references: 11504910
references: Ann N Y Acad Sci. 2000;899:349-62
references: 10863552
references: Breast Cancer Res. 2001;3(5):323-7
references: 11597322
references: Br J Cancer. 2001 Mar 23;84(6):844-50
references: 11259102
references: Mol Cancer Ther. 2006 May;5(5):1227-38
references: 16731755
references: Proc Nutr Soc. 2003 May;62(2):371-81
references: 14506884
references: Nat Rev Clin Oncol. 2009 Aug;6(8):465-77
references: 19581909
references: Cancer. 2005 Jan 15;103(2):422-31
references: 15597382
references: Oncologist. 2010;15(11):1179-91
references: 21045188
references: Curr Mol Med. 2012 Feb;12(2):163-76
references: 22280355
references: N Engl J Med. 1971 Nov 18;285(21):1182-6
references: 4938153
references: Eur J Clin Pharmacol. 2010 Aug;66(8):813-21
references: 20401474
references: J Biol Chem. 2004 Mar 26;279(13):12755-62
references: 14701854
references: Mutat Res. 1998 Jun 18;402(1-2):307-10
references: 9675322
references: BMC Cancer. 2008 Sep 30;8:279
references: 18826631
references: Cancer Res. 1991 Feb 1;51(3):794-8
references: 1846317
references: Crit Rev Food Sci Nutr. 2009 May;49(5):463-73
references: 19399671
references: Phytochemistry. 2006 Sep;67(17):1849-55
references: 16876833
references: Cancer Biol Ther. 2010 Oct 1;10(7):703-11
references: 20686367
references: Cancer Biol Ther. 2009 Mar 15;8(6):514-21
references: 19242105
references: Chem Biol Interact. 2010 May 14;185(3):247-52
references: 20346928
references: Int J Cancer. 2003 Sep 10;106(4):574-9
references: 12845655